GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (XMAD:ORY) » Definitions » Total Debt per Share

Oryzon Genomics (XMAD:ORY) Total Debt per Share : €0.00 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Oryzon Genomics Total Debt per Share?

€0.00 (As of Sep. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Oryzon Genomics's Total Debt Per Share for the quarter that ended in Sep. 2024 was €0.00.


Oryzon Genomics Total Debt per Share Historical Data

The historical data trend for Oryzon Genomics's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics Total Debt per Share Chart

Oryzon Genomics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.17 0.26 0.31 0.23

Oryzon Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.23 - 0.21 -

Oryzon Genomics Total Debt per Share Calculation

Oryzon Genomics's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Oryzon Genomics's Total Debt Per Share for the quarter that ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oryzon Genomics Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Oryzon Genomics Business Description

Traded in Other Exchanges
Address
Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.

Oryzon Genomics Headlines

No Headlines